View all news Print as PDF

MetLife Declares Fourth Quarter 2022 Preferred Stock Dividends

November 15, 2022

NEW YORK--(BUSINESS WIRE)-- MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends:

  • Quarterly dividend of $0.27126657 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: MET PRA).
  • Quarterly dividend of $351.5625 per share on the company’s 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE: MET PRE).
  • Quarterly dividend of $296.875 per share on the company’s 4.75% non-cumulative preferred stock, Series F, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.296875 per depositary share (NYSE: MET PRF).

The above dividends will be payable Dec. 15, 2022, to shareholders of record as of Nov. 30, 2022.

About MetLife
MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

Forward-Looking Statements
The forward-looking statements in this news release, which contain words such as “will,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it does not undertake any obligation to publicly correct or update any of these statements.

For Media:
Brian Blaser
212-578-2415
BBlaser@metlife.com

For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com

Source: MetLife, Inc.

Categories: Press Releases
View all news